Usefulness of fractional flow reserve in determining the indication of target lesion revascularization

Catheterization and Cardiovascular Interventions

Volumn 65, Issue 3, 2005, Pages 355-360

  Kobori, Yuichi ^a   Tanaka, Nobuhiro ^a   Takazawa, Kenji ^a   Yamashina, Akira ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Myocardial scintigraphy; Percutaneous coronary intervention; Restenosis

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; NICORANDIL; NITRATE;

ADULT; AGED; ANGINA PECTORIS; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FEMALE; FRACTIONAL FLOW RESERVE; HEART DEATH; HEART INJURY; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD FLOW VELOCITY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; REOPERATION;

EID: 21244445828     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20405     Document Type: Article

References (20)

1. Ormiston JA,Stewart FM, Rocke AHG, Webber BJ, Whitlock RML, Webster MWI. Late regression of the dilated site after coronary angioplasty: a 5-year quantitative angiographic study. Circulation 1997;96:468-474.
2. Kimura T, Yokoi H, Nakagawa Y, Tamura T, Kaburagi S, Sawada Y, et al. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med 1996;334:561-566.
3. Pijls NHJ, Van Gelder B, Van der Voort PH, Peels K, Bracke F, Bonnier HJRM, et al. Fractional flow reserve: a useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 1995;92:3183-3193.
4. Pijls NHJ, De Bruyne B, Peels K, Van der Voort PH, Bonnier HJRM, Bartunek J, et al. Measurement of fractional flow reserve to assess the functional severity of coronary artery stenosis. N Engl J Med 1996;334:1703-1708.
5. Bech GJ, Pijls NHJ, De Bruyne B, Peels KH, Michels HR, Bonnier HJRM, et al. Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty. Circulation 1999;99:883-888.
6. Hanekamp CEE, Koolen JJ, Pijls NHJ, Michels HR, Bonnier HJRM. Comparison of quantitative coronary angiography, intravascular ultrasound, and coronary pressure measurement to assess optimum stent deployment. Circulation 1999;99:1015-1021.
7. Pijls NHJ, Klauss V, Siebert U, Powers E, Takazawa K, Fearon WF, et al. Coronary pressure measurement after stenting predicts adverse events at follow up. Circulation 2002;105:126-130.
8. Shindo N, Tanaka N, Takazawa K, Yamashina A. Relation between coronary arterial remodeling and early loss of coronary artery lumen after plain old balloon angioplasty. Jpn J Interv Cardiol 2003;18:335-340.
9. Bech GJW, De Bruyne B, Bonnier HJRM, Bartunek J, Wijns W, Peels K, et al. Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement. J Am Coll Cardiol 1998;31:841-847.
10. Bech GJW, De Bruyne B, Pijls NHJ, De Muinck ED, Hoorntje JCA, Escaned J, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis. Circulation 2001;103:2928-2934.
11. Kern MJ, Donohue TJ, Aquirre FV, Bach RG, Caracciolo EA, Wolford T, et al. Clinical outcome of deferring angioplasty in patients with normal translesional pressure-flow velocity measurements. J Am Coll Cardiol 1995;25:178-187.
12. Pitt B, Waters D, Brown WV, Van Boven AJ, Schwartz L, Title LM, et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med 1999;341:70-76.
13. Chamuleau SAJ, Meuwissen M, Koch KT, Van Eck-Smit BLF, Tio RA, Tijssen JGP, et al. Usefulness of fractional flow reserve for risk stratification of patients with mutivessel coronary artery disease and an intermediate stenosis. Am J Cardiol 2002;89:377-380.
14. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease. Circulation 1996;93:905-914.
15. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998;32:57-62.
16. Beller GA, Zaret BL. Contibutions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 2000;101:1465-1468.
17. Chamuleau SAJ, Tio RA, De Cock CC, De Muinck ED, Pijls NHJ, Van Eck-Smit BLF, et al. Prognostic value of coronary blood flow velocity and myocardial perfusion in intermediate coronary narrowing and multivessel disease. J Am Coll Cardiol 2002;39:852-858.
18. Meuwissen M, Chamuleau SAJ, Siebes M, Schotborgh CE, Koch KT, De Winter RJ, et al. Role of variability in microvascular resistance on fractional flow reserve and coronary blood flow reserve in intermediate coronary lesions. Circulation 2001;103:184-187.
19. De Bruyne B, Pijls NHJ, Bartunek J, Kulecki K, Bech JW, De Winter H, et al. Fractional flow reserve in patients with prior myocardial infarction. Circulation 2001;104:157-160.
20. Usui Y, Chikamori T, Yanagisawa H, Morishima T, Hida S, Tanaka N, et al. Reliability of pressure-derived myocardial fractional flow reserve in assessing coronary artery stenosis in patients with previous myocardial infarction. Am J Cardiol 2003;92:699-702.